Panel Of Former US FDA Commissioners Make Renewed Call For Independent Agency
Former FDA heads reflected on instances when they experienced pressure from their higher-ups; speakers also offered praise for the job Commissioner Scott Gottlieb is doing at the agency.
You may also be interested in...
Robert Califf says there is a reason there is such a high turnover in the top post. He notes that the continuity and dedication of center directors is one of the reasons he returned.
Former commissioners continue push to move FDA out of HHS, but the alternative could create a different kind of political influence rather than eliminate it.
Bowing to President Trump’s latest push to authorize the anti-malarial drug for COVID-19 could damage the reputation of the agency for the duration of the pandemic and beyond, experts say, arguing it may be the best example yet of why the FDA’s decision making needs to be more clearly delineated from the country’s political leadership.